Drug profile · INN
triptorelin pamoate
TRELSTAR
triptorelin pamoate (TRELSTAR) is a gonadotropin-releasing hormone receptor agonist. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — triptorelin pamoate
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
triptorelin pamoate (TRELSTAR) is a gonadotropin-releasing hormone receptor agonist. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is triptorelin pamoate?
triptorelin pamoate (TRELSTAR) is a gonadotropin-releasing hormone receptor agonist. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for triptorelin pamoate?
TRELSTAR is a marketed brand name for triptorelin pamoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triptorelin pamoate?
triptorelin pamoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.